BIOCERES CROP SOLUTIONS CORP. Cost Of Sales
BIOCERES CROP SOLUTIONS CORP. (BIOX) reported Cost Of Sales of $47.15 million for the 3-month period ending 2025-12-31, per its 6-K filed 2026-03-13.
Financial Statements › Expense Statement
ifrs-full:CostOfSales · last filed 2026-03-13
- BIOCERES CROP SOLUTIONS CORP. cost of sales for the quarter ending 2025-12-31 was $47.15M, a 17.65% decline year-over-year.
- BIOCERES CROP SOLUTIONS CORP. cost of sales for the quarter ending 2025-09-30 was $41.30M, a 25.99% decline year-over-year.
- BIOCERES CROP SOLUTIONS CORP. cost of sales for the quarter ending 2025-06-30 was $49.34M, a 35.55% decline year-over-year.
- BIOCERES CROP SOLUTIONS CORP. cost of sales for the quarter ending 2025-03-31 was $36.74M, a 11.12% decline year-over-year.
| Period end | Cost Of Sales 3 month | Cost Of Sales 3 month as first filed | Cost Of Sales 6 month | Cost Of Sales 6 month as first filed | Cost Of Sales 9 month | Cost Of Sales 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $47.15M 6-K · filed 2026-03-13 | $85.52M 6-K · filed 2026-03-13 | $137.79M derived: sum of 3 quarters · filed 2026-03-13 | $174.53M derived: sum of 4 quarters · filed 2026-03-13 | ||
| 2025-09-30 | $41.30M 6-K · filed 2025-11-26 | $90.64M derived: sum of 2 quarters · filed 2025-11-26 | $127.37M derived: sum of 3 quarters · filed 2025-11-26 | $184.64M derived: sum of 4 quarters · filed 2026-03-13 | ||
| 2025-06-30 | $49.34M derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | $86.08M derived: sum of 2 quarters · filed 2025-11-10 | $143.34M derived: sum of 3 quarters · filed 2026-03-13 | $203.42M 20-F · filed 2025-11-10 | ||
| 2025-03-31 | $36.74M 6-K · filed 2025-06-20 | $94.00M derived: sum of 2 quarters · filed 2026-03-13 | $154.09M 6-K · filed 2025-06-20 | $226.35M derived: sum of 4 quarters · filed 2026-03-13 | ||
| 2024-12-31 | $57.26M 6-K · filed 2026-03-13 | $61.55M 6-K · filed 2025-02-28 | $109.56M 6-K · filed 2026-03-13 | $117.35M 6-K · filed 2025-02-28 | $189.61M derived: sum of 3 quarters · filed 2026-03-13 | $230.95M derived: sum of 4 quarters · filed 2026-03-13 |
| 2024-09-30 | $55.80M 6-K · filed 2025-11-26 | $132.35M derived: sum of 2 quarters · filed 2025-11-26 | $173.69M derived: sum of 3 quarters · filed 2025-11-26 | $262.40M derived: sum of 4 quarters · filed 2025-11-26 | ||
| 2024-06-30 | $76.56M derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | $117.90M derived: sum of 2 quarters · filed 2025-11-10 | $206.61M derived: sum of 3 quarters · filed 2025-11-10 | $278.22M 20-F · filed 2025-11-10 | ||
| 2024-03-31 | $41.34M 6-K · filed 2025-06-20 | $130.05M derived: sum of 2 quarters · filed 2025-06-20 | $201.66M 6-K · filed 2025-06-20 | $266.17M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2023-12-31 | $88.71M 6-K · filed 2025-02-28 | $160.33M 6-K · filed 2025-02-28 | $224.83M derived: sum of 3 quarters · filed 2025-11-10 | $260.97M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2023-09-30 | $71.62M 6-K · filed 2024-11-27 | $136.12M derived: sum of 2 quarters · filed 2025-11-10 | $172.26M derived: sum of 3 quarters · filed 2025-11-10 | $231.40M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2023-06-30 | $64.50M derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | $100.64M derived: sum of 2 quarters · filed 2025-11-10 | $159.78M derived: sum of 3 quarters · filed 2025-11-10 | $235.46M 20-F · filed 2025-11-10 | ||
| 2023-03-31 | $36.14M 6-K · filed 2024-05-29 | $95.28M derived: sum of 2 quarters · filed 2024-05-29 | $170.95M 6-K · filed 2024-05-29 | $240.28M derived: sum of 4 quarters · filed 2024-10-30 | ||
| 2022-12-31 | $59.14M 6-K · filed 2024-02-28 | $134.82M 6-K · filed 2024-02-28 | $204.14M derived: sum of 3 quarters · filed 2024-10-30 | $249.97M derived: sum of 4 quarters · filed 2024-10-30 | ||
| 2022-09-30 | $75.68M 6-K · filed 2023-11-29 | $145.00M derived: sum of 2 quarters · filed 2024-10-30 | $190.82M derived: sum of 3 quarters · filed 2024-10-30 | $246.16M derived: sum of 4 quarters · filed 2024-10-30 | ||
| 2022-06-30 | $69.33M derived: 20-F 12 month − 6-K 9 month · filed 2024-10-30 | $115.15M derived: sum of 2 quarters · filed 2024-10-30 | $170.48M derived: sum of 3 quarters · filed 2024-10-30 | $208.36M 20-F · filed 2024-10-30 | ||
| 2022-03-31 | $45.82M 6-K · filed 2023-05-24 | $101.16M derived: sum of 2 quarters · filed 2023-05-24 | $139.04M 6-K · filed 2023-05-24 | |||
| 2021-12-31 | $55.33M 6-K · filed 2023-02-28 | $93.22M 6-K · filed 2023-02-28 | ||||
| 2021-06-30 | $118.64M 20-F · filed 2023-11-14 | |||||
| 2020-12-31 | $25.07M 6-K · filed 2022-02-25 | $48.19M 6-K · filed 2022-02-25 | ||||
| 2020-06-30 | $93.58M 20-F · filed 2022-10-28 | |||||
| 2019-12-31 | $32.96M 6-K · filed 2021-02-26 | $53.31M 6-K · filed 2021-02-26 | ||||
| 2019-06-30 | $86.96M 20-F · filed 2021-10-29 | |||||
| 2018-12-31 | $33.15M 6-K/A · filed 2020-03-17 | $47.65M 6-K/A · filed 2020-03-17 | ||||
| 2018-06-30 | $77.09M 20-F · filed 2020-10-21 | |||||
| 2017-06-30 | $29.61M 20-F · filed 2019-10-24 | |||||
| 2016-12-31 | $30.60M 20-F · filed 2019-10-24 |